EMA Authorised: Pioglitazone Accord (pioglitazone hydrochloride) — Accord Healthcare S.L.U.

View source ↗

Summary

The EMA authorised Pioglitazone Accord (pioglitazone hydrochloride) for the treatment of Type 2 diabetes mellitus under Accord Healthcare S.L.U.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Pioglitazone Accord (pioglitazone hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus, Type 2. MAH: Accord Healthcare S.L.U.. Decision date: 19/08/2024